Ledger.Open graph →
SEC Form D · filed September 2, 2016

HEMISPHERX BIOPHARMA INC

Offering
$33K
Sold
$33K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Wayne K. Springate · Philadelphia, PAExecDavid K. Strayer · Philadelphia, PAExecAdam K. Pascale · Philadelphia, PAExecPeter W. Rodino · Philadelphia, PADirectorWilliam K. Mitchell · Philadelphia, PADirectorStewart W. Appelrouth · Philadelphia, PADirectorThomas K. Equels · Philadelphia, PAExec · DirectorMark Hanson · Chicago, ILDirectorDenise A. Archer · Grand Cayman, Cayman IslandsExecDavid A. Witkin · Redondo Beach, CADirectorRandall M. Stevens · BOSTON, MAExecArnold Oronsky · BOSTON, MAExec · DirectorChang K. Kim · Dania Beach, FLExecLalitendu K. Panda · Dania Beach, FLDirectorThomas W. Horner · Atlanta, GAExec · DirectorRobert N. Longo · Atlanta, GAExecJeffrey S. Meister · Newport Beach, CADirectorNicholas D. Tannura · Newport Beach, CADirectorJulia S. Pence · Newport Beach, CAExecCraig A. Leupold · Newport Beach, CADirectorAdriel Lares · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗